Main Article Content

Authors

Background: The Cali Population Cancer Registry (RPCC) has been in continuous operation since 1962 with the objective of producing valid statistics on the incidence of cancer, its patterns, trends and survival rates.

Methods: During the period 2008-2012, 23,046 new cases were registered and during 2011-2015 there were 12,761 cancer deaths. The trend of the rates was described with the APC average annual change rate and with the Joinpoint analysis. We analyzed the individual data of 38,671 adults (15-99 years) diagnosed with cancer between 1995-2009, and we calculated the standardized net survival by age for the 14 most common cancer body sites, using the Pohar-Perme method.

Results: Prostate and breast cancer were the first cause of cancer morbidity. The incidence rates in these susceptible to early detection, tumors stabilized after decades of growth, while an increase in the incidence of colon cancer and papillary thyroid carcinoma was observed. The incidence rates of cervical and stomach cancer, conditions related to infectious agents, decreased, although the number of absolute cases increased, due to the growth and aging of the population. Gastric cancer was responsible for the highest number of cancer deaths. The types of cancer related to tobacco consumption (lung, oral cavity, esophagus, pancreas, urinary bladder) showed low numbers and a tendency to decrease. During the period 2000-2004, the 5-year net survival improved for cancers of the breast, cervix, prostate, melanoma and thyroid, although in the period 2005-2009 a stagnation was observed. In stomach, liver and lung cancer, the 5-year net survival was less than 15%. The 5-year overall survival in children was 51.0% (95% CI: 47.5, 54.3) and in adolescents 44.6% (95% CI: 36.0, 52.8).

Comment: RPCC has been an advisor to the Colombian government in the evaluation of CPRs in the country and its data have contributed significantly to different aspects of cancer control in Colombia.

Luis Eduardo Bravo, 1 Registro Poblacional de Cáncer de Cali. Cali, Colombia 2 Departamento de Patología, Facultad de Salud, Universidad del Valle, Cali, Colombia.

1  Registro Poblacional de Cáncer de Cali. Cali, Colombia

2  Departamento de Patología, Facultad de Salud, Universidad del Valle, Cali, Colombia.

Luz Stella García, Registro Poblacional de Cáncer de Cali. Cali, Colombia

Registro Poblacional de Cáncer de Cali. Cali, Colombia

Paola Collazos, Registro Poblacional de Cáncer de Cali. Cali, Colombia

Registro Poblacional de Cáncer de Cali. Cali, Colombia

Edwin Carrascal, 1 Registro Poblacional de Cáncer de Cali. Cali, Colombia 2 Departamento de Patología, Facultad de Salud, Universidad del Valle, Cali, Colombia.

1  Registro Poblacional de Cáncer de Cali. Cali, Colombia

2  Departamento de Patología, Facultad de Salud, Universidad del Valle, Cali, Colombia.

Oscar Ramírez, 1 Registro Poblacional de Cáncer de Cali. Cali, Colombia 2 Fundación Pediatras OncoHEMAtólogos (Pohema). Cali, Colombia 3 Sistema de Vigilancia Epidemiologica de Cáncer Pediátrico (VIGICANCER), Cali, Colombia.

1  Registro Poblacional de Cáncer de Cali. Cali, Colombia
2  Fundación Pediatras OncoHEMAtólogos (Pohema). Cali, Colombia
3 Sistema de Vigilancia Epidemiologica de Cáncer Pediátrico (VIGICANCER), Cali, Colombia.

Armando Cortés, Departamento de Patología, Facultad de Salud, Universidad del Valle, Cali, Colombia.

Departamento de Patología, Facultad de Salud, Universidad del Valle, Cali, Colombia.

Marcela Nuñez, Registro Poblacional de Cáncer de Cali. Cali, Colombia

Registro Poblacional de Cáncer de Cali. Cali, Colombia

Erquinovaldo Millán, Secretaria de Salud Pública Municipal de Cali, Cali, Colombia.

Secretaria de Salud Pública Municipal de Cali, Cali, Colombia.
Bravo, L. E., García, L. S., Collazos, P., Carrascal, E., Ramírez, O., Cortés, A., Nuñez, M., & Millán, E. (2024). Reliable information for cancer control in Cali, Colombia. Colombia Medica, 49(1), 23–34. https://doi.org/10.25100/cm.v49i1.3689 (Original work published March 31, 2018)

Townsend JS, Moore AR, Mulder TN, Boyd M. What does a Performance Measurement System Tell Us about the National Comprehensive Cancer Control Program? J Publ Health managem Practice. 2015;21(5):449-458. doi:10.1097/PHH.0000000000000124.

Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, et al. Planning and developing population-based cancer registration in low- and middle-income settings. IARC Technical Publications; 43. Lyon: France, 2015. Available from: http://www.iarc.fr/en/publications/pdfs-online/treport-pub/treport-pub43/IARC_Technical_Report_No43.pdf

Pardo C, Cendales R. Cancer incidence estimates and mortality, five first types of cancer in Colombia 2007-2011. Colomb Med (Cali). 2018; 49(1): 16-22.

Plan Decenal para el Control del Cáncer en Colombia, 2012 – 2021. Bogota: Ministerio de Salud y Protección Social - Instituto Nacional de Cancerología, ESE, 2012. Available from: http://www.cancer.gov.co/files/libros/archivos/incidencia1.pdf

Bravo LE, Collazos T, Collazos P, García LS, Correa P. Trends of cancer incidence and mortality in Cali, Colombia. 50 years experience. Colomb Med (Cali). 2012;43(4):246-55.

Yepez MC, Jurado DM, Bravo LM, Bravo LE. Incidencia, mortalidad y supervivencia del cáncer en Pasto, Colombia. Colomb Med (Cali). 2018; 49(1): 42-54.

Arias-Ortiz N, López-Guarnizo G, Arboleda-Ruiz W. Cancer incidence and mortality in Manizales 2003-2007. Colomb Med (Cali). 2012;43(4):289.

Uribe PCJ, Serrano GSE, Hormiga SCM. Cancer incidence and mortality in the Bucaramanga metropolitan area, 2008-2012. Colomb Med (Cali). 2018; 49(1): 73-80.

Vargas Moranth R, Navarro Lechuga E. Cancer Incidence and Mortality in Barranquilla, 2008-2012 Colomb Med (Cali). 2018; 49(1): 55-62.

Brome BMR, Montoya RDM, Salcedo LA. Cancer Incidence and Mortality in Medellin-Colombia, 2010-20. Colomb Med (Cali). 2018; 49(1): 81-88.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.

Cendales R, Pardo C. Colombia death certificate quality. Colomb Med (Cali). 2018; 49(1):121-127

Colombia. Departamento Administrativo Nacional de Estadística. Estimaciones y proyecciones de población periodo 1985-2020. Bogotá: Departamento Administrativo Nacional de Estadística. DANE; 2010.

Cuantos somos Como vamos. Diagnóstico Sociodemográfico de Cali y 10 municipios del Pacífico nariñense. Departamento Administrativo Nacional de Estadística DANE - Equipo de Grupos Étnicos de la Dirección de Censos y Demografía. Cali: Afroamericana XXI, 2011.

Pan American Health Organization. Health in the Americas: 2012 Edition. Regional Outlook and Country Profiles. Washington, DC: PAHO, 2012.

Suarez MA, Aguilera J, Salguero EA, Wiesner C. Offer of pediatric oncology services in child cancer care centers in Colombia. Colomb Med (Cali). 2018; 49(1): 97-101.

Correa P, Llanos G. Morbidity and mortality from cancer in Cali, Colombia. J Natl Cancer Inst. 1966;36(4):717-45.

García LS, Bravo LE, Collazos P, Ramírez O, Carrascal E, Nuñez M, Portilla N, Millán E. Methods and procedures of the Population-Based Cancer Registry of Cali, Colombia. Colomb Med (Cali). 2018; 49(1): 109-120.

Ramirez O, Aristizabal P, Zaidi A, Ribeiro, R. C., Bravo, LE, VIGICANCER Working Group. Implementing a childhood cancer outcomes surveillance system within a population-based cancer registry. J Global Oncol. 2018; 4:1-11.

Bravo LE, García LS, Collazos P, Aristizabal P, Ramirez O. Descriptive epidemiology of childhood cancer in Cali, Colombia 1977-2011. Colomb Med (Cali). 2013;44(3):155-164.

Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer. Cancer. 2005; 103(7): 1457-67.

Bravo L, García L, Collazos P. Cancer survival in Cali, Colombia: A population-based study, 1995-2004. Colomb Med (Cali). 2014; 3: 110-16.

Sanz C. Out-of-Sync Cancer Care: Health Insurance Companies, Biomedical Practices, and Clinical Time in Colombia. Med Anthropol. 2017;36(3):187-201. DOI: 10.1080/01459740.2016.1267172.

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125): 1023-1075

Gelband H, Sloan FA, eds. Cancer control opportunities in low-and middle-income countries. National Academies Press. 2007.

Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Prevention Biomarkers. 2016; 25(1): 16-27.

Piazuelo MB, Correa P. Gastric cancer: overview. Colomb Med (Cali). 2013; 44(3):192-201.

Muñoz N, Bravo LE. Epidemiology of cervical cancer in Colombia. Colomb Med (Cali). 2012;43(4):298-304.

IARC Helicobacter pylori Working Group. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports, No. 8); 2014. Available from: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php

Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, et al. Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017; 15(12):1833-1843. doi: 10.1016/j.cgh.2017.05.023.

Pisani P, Oliver WE, Parkin DM, Alvarez N, Vivas J. Case-control study of gastric cancer screening in Venezuela. Br J Cancer. 1994; 69(6):1102-5.

Rosero-Bixby L, Sierra R. X-ray screening seems to reduce gastric cancer mortality by half in a community-controlled trial in Costa Rica. Br J Cancer. 2007;97(7):837-43.

Llorens P. Gastric cancer mass survey in Chile. Semin Surg Oncol. 1991;7(6):339-43.

Sugano K. Prevention of gastric cancer: urgent need to implement Helicobacter pylori eradication therapy as a primary preventive measure in Japan. J Gastroenterol. 2007;42 Suppl 17:1-2.

Sugano K. Strategies for Prevention of Gastric Cancer: Progress from Mass Eradication Trials. Dig Dis. 2016;34(5):500-4.

Aristizabal N, Cuello C, Correa P, Collazos T, Haenszel W. The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer. 1984;34(1):5-9.

Palacios R. Considerations on immunization anxiety-related reactions in clusters. Colomb Med (Cali). 2014; 45(3): 136-140.

Restrepo J. A., Bravo L. E., García-Perdomo H. A., García L. S., Collazos P., Carbonell J. Incidencia, mortalidad y supervivencia al cáncer de próstata en Cali, Colombia, 1962-2011. Salud Pública Mex. 2014; 56: 440-447.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer. Disponible en: http://publications.iarc.fr/Databases/Iarc-Cancerbases/Globocan-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1-0-2012.

Cortes A, Bravo LE, García LS, Collazos P. Incidencia, mortalidad y supervivencia por cáncer colorrectal en Cali, Colombia, 1962-2012. Salud Pública Mex. 2014;56(5):457-464.

Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol. 2005; 16(3): 489-511.

Menezes A, Lopez M, Hallal P, Muiño A, Perez-Padilla R, Jardim J. Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study. BMC Pub Health. 2009; 9: 151.

Perme M, Stare J, Estève J. On estimation in relative survival. Biometrics. 2012;68:113-120

Clerc-Urmès I, Grzebyk M, Hédelin G. Net survival estimation with stns. Stata J. 2014; 14(1):87-102.

Danieli C, Remontet L, Bossard N, Roche L, Belot A. Estimating net survival: the importance of allowing for informative censoring. Statistics Med. 2012;(31):775-786.

Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159-174.

Kellie SJ, Howard SC: Global child health priorities: What role for paediatric oncologists?. Eur J Cancer. 2008; 44(16):2388-2396

Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L, et. al. Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol. 2015;33(27):3065.

Magrath I, Steliarova-Foucher E, Epelman S, Ribeiro RC, Harif M, Li CK, et. al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013;14(3):e104-e116.

Gatta, G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel, J, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1): 35-47.

Ward E, DeSantis C, Robbins A, Kohler B, Jemal, A. Childhood and adolescent cancer statistics. 2014; CA Cancer J Clin. 2014;64(2):83-103.

Moreno F, Dussel V, Orellana L. Childhood cancer in Argentina: Survival 2000–2007. Cancer Epidemiol. 2015;39(4): 505-510.

Downloads

Download data is not yet available.
1 2 3 4 5 6 > >> 
Received 2017-12-13
Accepted 2018-02-13
Published 2024-05-31

Similar Articles

You may also start an advanced similarity search for this article.